Burundi vs Wallis and Futuna Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Burundi
0.4%
in 2024
Wallis and Futuna Islands
0.4%
in 2024
Burundi rank
75th
Wallis and Futuna Islands rank
75th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Burundi
- Wallis and Futuna Islands
How they compare
Burundi currently reports 0.4% against 0.4% in Wallis and Futuna Islands, a difference of 0.0%.
Across all 10 years both countries report, Wallis and Futuna Islands has been ahead every year.
Burundi ranks 75th and Wallis and Futuna Islands ranks 75th of 247 countries.
Wallis and Futuna Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Burundi | Wallis and Futuna Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 1.0% | 0.6% | Wallis and Futuna Islands |
| 2020s | 0.4% | 0.7% | 0.3% | Wallis and Futuna Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Burundi or Wallis and Futuna Islands?
- Burundi, at 0.4% against 0.4% in Wallis and Futuna Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Burundi and Wallis and Futuna Islands?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Wallis and Futuna Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Burundi and Wallis and Futuna Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Burundi ranks 75th and Wallis and Futuna Islands ranks 75th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.